Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares Issued
Ratios

Merit Medical Systems (MMSI) R&D In Process (2016 - 2023)

Historic R&D In Process for Merit Medical Systems (MMSI) over the last 9 years, with Q2 2023 value amounting to $1.5 million.

  • Merit Medical Systems' R&D In Process fell 7676.51% to $1.5 million in Q2 2023 from the same period last year, while for Dec 2023 it was $1.5 million, marking a year-over-year decrease of 7676.51%. This contributed to the annual value of $1.5 million for FY2023, which is 7676.51% down from last year.
  • Latest data reveals that Merit Medical Systems reported R&D In Process of $1.5 million as of Q2 2023, which was down 7676.51% from $6.7 million recorded in Q2 2022.
  • In the past 5 years, Merit Medical Systems' R&D In Process registered a high of $6.7 million during Q2 2022, and its lowest value of $25000.0 during Q1 2019.
  • Over the past 3 years, Merit Medical Systems' median R&D In Process value was $1.0 million (recorded in 2019), while the average stood at $2.2 million.
  • As far as peak fluctuations go, Merit Medical Systems' R&D In Process soared by 6339.87% in 2019, and later plummeted by 7676.51% in 2023.
  • Merit Medical Systems' R&D In Process (Quarter) stood at $500000.0 in 2019, then skyrocketed by 1234.2% to $6.7 million in 2022, then crashed by 76.77% to $1.5 million in 2023.
  • Its R&D In Process stands at $1.5 million for Q2 2023, versus $6.7 million for Q2 2022 and $500000.0 for Q2 2019.